Key result
Sparing the S-ICD during arrhythmia radioablation reduces lateral plan quality, though ~90% remain clinically acceptable.
Why the study?
Due to placement near the left lateral and apical myocardium, S-ICDs can present technical challenges for STAR of ventricular tachycardia, leaving its feasibility unestablished.
Does sparing the S-ICD from the primary radiotherapy beam affect the dosimetric feasibility and plan quality of stereotactic arrhythmia radioablation for ventricular tachycardia?
Observational (n=10)
Does sparing the S-ICD from the primary radiotherapy beam affect the dosimetric feasibility and plan quality of stereotactic arrhythmia radioablation for ventricular tachycardia?
p-value: p=<0.05
The presence of an S-ICD is not a contraindication for stereotactic arrhythmia radioablation, although plan quality may decrease when targeting lateral segments.
Background and purpose: Subcutaneous implantable cardioverter defibrillators (S-ICDs) are increasingly used to prevent sudden cardiac death. Due to their placement near the left lateral and apical myocardium, S-ICDs can present technical challenges for stereotactic arrhythmia radioablation (STAR) of ventricular tachycardia. This study aimed to evaluate the feasibility of STAR in patients with S-ICDs. Materials and methods: Previously acquired cardiac computed tomography data from ten S-ICD patients were retrospectively analyzed. Organs at risk, S-ICD components, and hypothetical planning target volumes (PTV) for segments 8 (septal), 11 (lateral), and 17 (apical) were contoured. For each patient and segment, two treatment plans were calculated with a prescribed PTV dose of 25 Gy: one plan sparing the S-ICD from the primary radiotherapy beam ('spared') and one without this constraint ('non-spared'). Results: exceeded 1 Gy. Spared plans for PTV segment 11 showed significant higher dose/volume metrics and reduced plan quality compared to non-spared plans (p < 0.05), although 9/10 plans remained clinically acceptable. For PTV segment 8 and segment 17, no clinical or statistical differences were observed. Conclusions: The presence of an S-ICD is not a contraindication for STAR, although plan quality may decrease with PTVs in lateral segments. Rare cases with a distance between PTV and S-ICD <4 cm may complicate radiation treatment planning.
No takes yet. Share an insight, caveat, or question.
Kaestner et al. (2025) conducted an observational in Ventricular tachycardia in patients with a subcutaneous implantable cardioverter defibrillator (n=10). Stereotactic arrhythmia radioablation (STAR) with S-ICD sparing vs. STAR without S-ICD sparing (non-spared) was evaluated on Dose/volume metrics and plan quality (p=<0.05). Sparing the S-ICD during stereotactic arrhythmia radioablation reduced plan quality for lateral segments compared to non-spared plans (p<0.05), though 9 of 10 plans remained clinically acceptable.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: